skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

25 Total results for product and free and sample content found

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 19 Aug 2017

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deal trends


Maximize your drugs market potential in a payer dominated world

17 Aug 2017

See how the value of drugs differentiate therapies by sub-population. Find out where the disproportionate value of your drug lies alongside competitors. Uncover demonstrable differentiated value when entering a crowded market. Discover the power of RxScorecard™.

Topic Reimbursement

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 17 Aug 2017

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Datamonitor Healthcare

Big Pharma Outlook 2026 Pharmavitae Analytics Repot Extract

05 Aug 2017

Big Pharma Outlook 2026 takes decade-long look at what’s in store for the future of Big Pharma.


Report Extract: Q3 2017 Outlook Report

17 Jul 2017

In this report, we cover catalysts from 21 drugs expected to occur in Q3 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic Alzheimers Cancer Drug approval

Strategic Transactions, Scrip

Building something great: UK's Global Bioscience Cluster 2016

22 May 2017

Featured recently in The Telegraph and The Times, Building something great: UK’s Global Bioscience Cluster 2016, the pivotal report from Informa Pharma Intelligence and The UK BioIndustry Association, is now available to you in its entirety as a free download.


Pharma R&D Annual Review 2017 Supplement

By Ian Lloyd 13 Apr 2017

Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2017, this supplement takes a look at the industry’s success stories of 2016 – the drugs which were launched on to the market for the first time during the year.


Finding Finance: Pharma, Biotech & Medtech Capital Raising 2016

23 Mar 2017

There is no doubt that 2016 will be marked as year of surprising results. None more so than how life science companies fared in the capital markets.

Topic Business strategies


A Bird’s-Eye View of the Rare Disease Landscape

27 Feb 2017

Over 350 million people worldwide are suffering from rare diseases. Which is why it is necessary to understand the rare disease landscape to date.

Topic Clinical trials Diseases Rare Disease

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: